---
document_datetime: 2023-09-21 17:55:13
document_pages: 2
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/neospect-epar-procedural-steps-taken-and-scientific-information-after-authorisation_en.pdf
document_name: neospect-epar-procedural-steps-taken-and-scientific-information-after-authorisation_en.pdf
version: success
processing_time: 1.6656482
conversion_datetime: 2025-12-30 20:21:29.935061
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
<!-- image -->

| No     | Scope                                      | Opinion issued on   | Commission Decision Issued/ amended on   | Product Information affected 2   | Summary                                                                                                                      |
|--------|--------------------------------------------|---------------------|------------------------------------------|----------------------------------|------------------------------------------------------------------------------------------------------------------------------|
| T/0009 | Transfer of Marketing Authorisation Holder | 03/03/2006          | 22/03/2006                               | SPC, Labelling, PL               | longer Amersham Health AS submitted an application for the transfer of the Marketing Authorisation to CIS bio international. |
| R/0006 | Renewal of the marketing authorisation     | 15/09/2005          | 31/01/2006                               | SPC, Annex II, Labelling, PL     |                                                                                                                              |

| No      | Scope                                                                                                    | Product Information affected 2   | Date 4     |
|---------|----------------------------------------------------------------------------------------------------------|----------------------------------|------------|
| N/0015  | product Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification) | PL                               | 11/04/2008 |
| N/0014  | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)         | Labelling, PL                    | 17/08/2007 |
| N/0013  | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)         | PL                               | 22/09/2006 |
| IB/0012 | 37_a_Change in the specification of the finished product - tightening of specification limits            |                                  | 01/08/2006 |
| IB/0011 | 37_a_Change in the specification of the finished product - tightening of specification limits            |                                  | 01/08/2006 |
| IA/0010 | 08_b_01_Change in BR/QC testing - repl./add. manuf. responsible for BR - not incl. BC/testing            | SPC, Annex II, PL                | 29/05/2006 |
| IB/0008 | 13_b_Change in test proc. for active substance - other changes (replacement/addition)                    |                                  | 10/11/2005 |
| IB/0007 | 13_b_Change in test proc. for active substance - other changes (replacement/addition)                    |                                  | 10/11/2005 |
| N/0005  | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)         | Labelling, PL                    | 22/07/2005 |

2

<!-- image -->

Medicinal product no longer authorised NeoSpect Procedural steps taken and scientific information after the authorisation Changes made after 01/06/2003 For procedures finalised before 01/06/2003, please refer to module 8A MAJOR CHANGES 1 Summary Amersham Health AS submitted an application for the transfer of the Marketing Authorisation to CIS bio international. MINOR CHANGES 3 1 Major changes e.g. Type II variations, Annex II applications, Renewals and Annual Reassessments SPC (Summary of Product Characteristics), Annex II, Labelling, PL (Package Leaflet) 3 Minor changes e.g. Type I variations and Notifications 4 Date of entry into force of the change

<div style=\"page-break-after: always\"></div>

| No      | Scope                                                                                 | Product Information affected 2 Date 4   |
|---------|---------------------------------------------------------------------------------------|-----------------------------------------|
| IB/0004 | 13_b_Change in test proc. for active substance - other changes (replacement/addition) | 26/03/2004                              |

<!-- image -->